Epigenetic modulation represents a new frontier of pharmaceutical research that is attracting significant attention owing to the potential to differentially regulate gene expression for therapeutic benefit. Within this area there exist several novel target classes that through pharmacological manipulation could build upon the success of the histone deacetylases (HDAC) inhibitors in oncology and extend therapeutic benefits to a broad range of therapeutic indications.
18 July, 2013
The latest issue of Drug Discovery Today is packed full of industry focused research articles, new developments in drug discovery, and expert comment and opinion.
01 July, 2013